With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...
On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...
Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which ...
When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients foot the bill.
Eli Lilly said last night it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation ...
On February 2, 2024, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – released a discussion draft bill intended ...
Two recent federal court cases signal new significant developments with respect to the 340B Drug Pricing Program. Specifically: (1) new federal district court litigation challenging a recent HRSA ...
OPINION—There are many barriers to equitable health care in California, the cost of prescription drugs being central among ...
The Well News on MSNOpinion
How to lower health costs and improve access
In April, members of Congress questioned hospital CEOs about the rising cost of health care - and particularly criticized ...
The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results